# MediQ Star Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mediq-star-co

- Industry: Healthcare IT
- Headquarters: Seongnam, South Korea
- Website: www.mediqstar.com/
- Latest round: Series A (Jul 3, 2025)
- Investors on record: 2

## About

Based in Seongnam-si, South Korea, and founded in 2023 by CEO Seung-Jae Yoo, MediQ Star Co., Ltd. operates as a provider of advanced diagnostic tools and AI-driven healthcare solutions to support clinical decision-making and patient management across hospitals and clinics. The company is currently led by CEO Jong-eon Lim. In August 2026, MediQ Star Co., Ltd. raised an undisclosed amount of pre-series B funding from new investor Genaxis.

The company provides a wide range of healthcare technology solutions, such as AI-powered clinical research tools (AI CRO), tuberculosis diagnostic kits (TB Kit), and related technologies. MediQstar strategically positions its products in South Korea, Japan, and other Asian markets, serving healthcare professionals, institutions, and technology partners, and addressing critical healthcare challenges related to timely diagnosis and personalized patient care.

MediQstar's revenue model is structured around B2B transactions, focusing on partnerships with healthcare institutions and technology service providers. Their flagship products are offered through subscription-based models, ensuring continuous access to software updates and support, which fosters long-term relationships with clients.

The company plans to use the August 2026 funding to commercialize its technology globally and further develop its medical artificial intelligence diagnostic technologies.

## Funding rounds

- Series A, Jul 3, 2025 — HB Investment
- Series A, Jan 22, 2025 — Pathfinder H

## Investors

- Pathfinder H (https://capitalatlas.ai/funds/pathfinder-h) — Series A
- HB Investment (https://capitalatlas.ai/funds/hb-investment) — Series A